Pharsight

1. Rezzayo patents expiration

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US11654196	CIDARA THERAPS	Dosing regimens for echinocandin class compounds	Mar, 2032 (8 years from now)
US8722619	CIDARA THERAPS	Antifungal agents and uses thereof	Mar, 2032 (8 years from now)
US10702573	CIDARA THERAPS	Dosing regimens for echinocandin class compounds	Mar, 2033 (9 years from now)
US9526835	CIDARA THERAPS	Dosing regimens for echinocandin class compounds	Mar, 2033 (9 years from now)
US11197909	CIDARA THERAPS	Compositions and methods for the treatment of fungal infections	Jul, 2038 (14 years from now)
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11712459	CIDARA THERAPS	Dosing regimens for treatment of fungal infections	Mar, 2037 (13 years from now)